Lower motor neuron disease and signs of dysimmunity;Maladies du neurone moteur peripherique et signes de dysimmunite

Revue Neurologique

Volumn 156, Issue 4, 2000, Pages 372-379

  Azulay, J Ph ^b   Attarian, S ^b   Boucraut, J ^a   Pouget, J ^b  

^a TIMONE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; ALKYLATING AGENT; ANTIIDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; ELECTRODIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LYMPHOPROLIFERATIVE DISEASE; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MOTOR NEURON DISEASE; MUSCLE ATROPHY; MUSCLE WEAKNESS; HOSPITALIZATION; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL NERVE; SKELETAL MUSCLE;

ADOLESCENT; ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; G(M1) GANGLIOSIDE; HUMANS; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; MUSCLE, SKELETAL; PERIPHERAL NERVES; SEVERITY OF ILLNESS INDEX;

EID: 0034015136     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ad Hoc subcommitee of the AAN. Research criteria for diagnosis of CIDP. (1991). Neurology, 41: 617-618.
2. AZULAY J-Ph, BLIN O, BOUCRAUT J, POUGET J, SERRATRICE G. (1994). Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind placebo controlled trial. Neurology, 44: 429-432.
3. BADY B, VIAL C, BRUDON F, LAPRAS J, KOPP N, TRILLET M. (1988). Neuropathies périphériques simulant une sclérose latérale amyotrophique au cours des gammapathies. Rev Neurol (Paris), 11: 710-715.
4. BRUYN RP, KOELMAN JH, TROOST D, DE JONG JM. (1995). Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. J Neurol Neurosurg Psychiatry, 58: 742-744.
5. BILLÉ-TURC F, BILLÉ J, AZULAY J-Ph. PADOVANI R, SERRATRICE G. (1996). La maladie d'Hirayama, maladie ou syndrome. Rev Neurol (Paris), 1: 20-26.
6. BRAHE C, SERVIDEI S, ZAPPATA S, RICCI E, TONALLI P, NERI G. (1995). Genetic homogeneity between childhood-onset and adut-onset autosomal recessive spinal muscular atrophy. Lancet, 346: 741-742.
7. DYCK PJ. Are motor neuropathies and motor neuron diseases separable. (1982). In LP Rowland (eds.). Human motor neuron disease, pp. 105-114. Raven Press. New York.
8. El Escorial World Federation of Neurology. (1990). Criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci, 124 (suppl): 96-107.
9. FREDDO L, YU RK, LATOV N, DONOFRIO PD, HAYS AP, GREENBERG HS, ALBERS JW, ALLESSI AG, KEREN D. (1986). Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology, 36: 454-458.
10. GORDON PH, ROWLAND LP, YOUNGER DS, SHERMAN WH, HAYS AP, LOUIS ED, LANGE DJ, TROJABORG W, LOVELACE RE, MURPHY PL, LATOV N. (1997). Lymphoproliferative disorders and motor neuron disease: an update. Neurology, 48: 1671-1678.
11. HAHN AF, BOLTON CF , ZOCHODNE D, FEASBY TE. (1996). Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain, 119: 1067-1077.
12. HARDING AE, THOMAS PK. Hereditary distal muscular atrophy. (1980). J Neurol Sci, 45: 337-348.
13. KRARUP C, STEWART JD, SUMNER AJ, PESTRONK A, LIPTON SA. (1990). A syndrome of asymetric limb weakness with motor conduction block. Neurology, 40: 118-127.
14. KRIEGER C, MELMED C. (1982 ). Amyotrophic lateral sclerosis and paraproteinemia. Neurology, 32: 896-898.
15. LOUIS ED, HANLEY AE, BRANNAGAN TH, SHERMAN W, MURPHY P, LANGE DJ, TROJABORG W, YOUNGER DL, LOVELACE R, ROWLAND LP. (1996). Motor neuron disease, lymphoproliferative disease, and bone marrow biopsy. Muscle Nerve, 19: 1334-1337.
16. MELKI J, LEFEBVRE S, BURGLEN L, BURLET P, CLERMONT O, MILLASSEAU P, REBOULLET S, BÉNICHOU B, ZEVIANI M, LE PASLIER D, COHEN D, WEISSENBACH J, MUNNICH A. (1994). De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. Science, 264: 1474-1477.
17. MOULARD B, SALACHAS F, CHASSANDE B, BRIOLOTTI V, MEININGER V, MALAFOSSE A, CAMU W. (1998). Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease. Ann Neurol, 43: 640-644.
18. NARDELLI E, STECK AJ, BARKAS T, SCHLUEP M, JERUSALEM F. (1988). Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b. Ann Neurol, 23: 524-528.
19. PAKIAM ASI, PARRY GJ. (1998). Multifocal motor neuropathy without conduction block. Muscle Nerve, 21: 243-245.
20. PARRY GJ, HOLTZ SJ, BEN-ZEEV D, DRORI JB. (1986). Gammopathy with proximal motor axonopathy simulating motor neuron disease. Neurology, 36: 273-276.
21. PARRY GJ, CLARKE S. (1988). Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve, 11: 102-107.
22. PESTRONK A, CORNBLATH DR, ILYAS AA, BABA H, QUARLES RH, GRIFFIN JW ALDERSON K, ADAMS RN. (1988). A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol, 24: 73-78.
23. PESTRONK A. (1991). Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve, 14: 927-936.
24. PESTRONK A, LOPATE G, KORNBERG AJ, ELLIOTT JL, BLUME G, YEE WC, GOODNOUGH LT. (1994). Distal motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intrevenous cyclophosphamide. Neurology, 44: 2027-2031.
25. PETERS HA, CLATANOFF DV. (1968). Spinal muscular atrophy secondary to macroglobulinemia. Reversal with chlorambucil therapy. Neurology, 18: 101-108.
26. ROWLAND LP. Diverse forms of motor neuron diseases. (1982). In LP Rowland (eds.). Human motor neuron disease, pp. 1-13. Raven Press. New-York.
27. ROWLAND LP, DEFENDINI R, SHERMAN W, HIRANO A, OLARTE MR, LATOV N, LOVELACE RE, INOUE K, OSSERMAN EF. (1982). Macroglobulinemia with peripheral neuropathy simulating motor neuron disease. Ann Neurol, 11: 532-536.
28. ROWLAND L.P. Peripheral neuropathy, motor neuron disease, or neuronopathy? (1983). In: Clinical and biological aspects of peripheral nerve diseases. pp. 27-41. Alan R. Riss New-York.
29. RUDNICKI S, CHAD DA, DRACHMAN DA, SMITH TW, ANWER UE, LEVITAN N. (1987). Motor neuron disease and paraproteinemia. Neurology, 37: 335-337.
30. SADIQ SA, THOMAS FP, KILIDEREAS K, PROTOPSALTIS S, HAYS AP, LEE KW, ROMAS SN, KUMAR N, VAN DEN BERG L, SANTOTO M, LANGE DJ, YOUNGER DS, LOVELACE RE, TROJABORG W, SHERMAN WH, MILLER JR, MINUK J, FEHR MA, ROCLOFS RI, HOLLANDER D, NiCHOLS FT, MITSUMOTO H, KELLY JJ, SWIFT TR, MUNSAT TL, LATOV N. (1990). The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology, 40: 1067-1072.
31. SERRATRICE G. Amyotrophie spinale distale chronique localisée aux membres supérieurs (type O'Sullivan et Mc Leod). (1984). Rev Neurol, 5 : 368-369.
32. SHY ME, ROWLAND LP, SMITH T, THOJABORG W, LATOV N, SHERMAN S, PESCE M, LOVELACE RE, OSSERMAN EF. (1986). Motor neuron disease and plasma cell dyscrasia. Neurology, 36: 1429-1436.
33. SHY ME, HEIMAN-PATTERSON T, PARRY GJ, TAHMOUSH A, EVANS VA, SCHICK PK. (1990). Lower motor neuron disease in a patient with autoantibodies against Gal (b1-3)GalNAc in gangliosides GM1 and GD1b: Improvement following immunotherapy. Neurology, 40: 842-844.
34. TAN E, LYNN J, AMATO AA, KISSEL JT, RAMMOHAN KW, SAHENK Z, WAMOLTS JR, JACKSON CE, BAROHN RJ, MENDELL JR. (1994). Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder. Arch Neurol, 51: 194-200.
35. TREFOURET S, AZULAY J Ph, PERETTI P, POUGET J. (1997). Comparative evaluation of pyramidal tract in amyotrophic lateral sclerosis and in primary lateral sclerosis. Neurology (abst), 48: 129.
36. TSAI CP, LIN KP, LIAO KK, WANG SJ, WANG V, KAO KP, WU ZA. (1993). Immunosuppressive treatment in lower motor neuron syndrome with autoantibodies against GM1 ganglioside. Eur Neurol, 33: 446-449.
37. YOUNGER DS, ROWLAND LP, LATOV N, HAYS AP, LANGE DJ, SHERMAN W, INGHIRAMI G, PESCE MA, KNOWLES DM, POWERS J, MILLER JR, FETELL MR, LOVELACE RE. (1991). Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol, 29: 78-86.
38. World Federation of Neurology Research Group on Neuromuscular Diseases (1994). Classification of Neuromuscular disorders. J Neurol Sci, 124 (suppl): 109-130.